Find our press releases, our mediakit
and get in touch with us.
Check our newest
Keep up with the latest news from Cansativa – from product launches and successes to our latest positions on current political developments.
About Cansativa Group
The Cansativa Group is the market leader in the medical cannabis market and sees itself as a driving force of the cannabis industry in Germany. Since the award of the contract by the Federal Institute for Drugs and Medical Devices (BfArM) in August 2020, they are the only company with approval for the distribution of medical cannabis from German cultivation. In the upcoming cannabis legalization, athe Cansativa Group sees itself as a pioneer in the democratization of the cannabis market.
AMICI takes the next step – leading the premium medical cannabis market with new THC levels.
The changes to the pharmaceutical guidelines by the G-BA carry great risks
AMICI - Premium medical cannabis enabled by Cansativa
DEMECAN liefert zweite Sorte aus eigenem Anbau an die Cannabisagentur..
Cansativa Group and Akanda Corp. to Bring New Medical Cannabis Flowers to Germany
Cansativa Group schließt Finanzierungsrunde über 13 Millionen Euro ab.
All information on the Cansativa Group in our media kit (PDF), including most relevant information and portraits.
Get in touch
For press inquiries or journalistic queries of any kind, please contact:
Recently Seen On